1. Bioorg Med Chem Lett. 2005 Oct 1;15(19):4174-9. doi:
10.1016/j.bmcl.2005.06.089.

Identification of ortho-amino benzamides and nicotinamides as MCHr1 antagonists.

Vasudevan A(1), LaMarche MJ, Blackburn C, Che JL, Luchaco-Cullis CA, Lai S, 
Marsilje TH, Patane MA, Souers AJ, Wodka D, Geddes B, Chen S, Brodjian S, Falls 
DH, Dayton BD, Bush E, Brune M, Shapiro RD, Marsh KC, Hernandez LE, Sham HL, 
Collins CA, Kym PR.

Author information:
(1)Metabolic Diseases Research, Global Pharmaceutical Research and Development, 
Abbott Laboratories, Abbott Park, IL 60064, USA. Anil.Vasudevan@abbott.com

Several potent and efficacious MCHr1 antagonists containing an ortho-amino 
benzamide or nicotinamide chemotype have been identified, exemplified by 28 and 
50.

DOI: 10.1016/j.bmcl.2005.06.089
PMID: 16085414 [Indexed for MEDLINE]
